The Shingles market report provides current treatment practices, emerging drugs, Shingle’s market share of the individual therapies, current and forecasted Shingles market Size from 2017 to 2030 segmented by seven major markets. Unlike herpes simplex virus infections, which can recur many times, there is usually only one outbreak of shingles in a person’s lifetime. Fewer than 4% of people have more than one outbreak.
The Report also covers current Shingles treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Some of the key highlights of the Shingles Market Report Insights
- An estimated one million cases of herpes occur annually in the United States.
- Females are more commonly affected by Shingles than males.
- The Major players of the Shingles Market like Novartis, GlaxoSmithKline, Maruho, and many others are involved in the report.
- The Shingles Marketed Therapies such as Famvir (famciclovir), Valtrex (Valacyclovir), Amenalief (amenamevir), Shingrix, and many others are involved in the report.
Request for sample for deep insights into Shingles Market Report
Shingles, also known as herpes zoster (HZ), is a viral infection caused by the chickenpox virus, varicella-zoster virus (VZV). Herpes zoster results from activation of the virus, which in many instances has remained latent for years following a primary chickenpox infection. Once active, the virus travels along a nerve to the skin and causes a rash.
Shingles Epidemiology Segmentation in the 7MM for the Study period 2017-2030.
- Total Shingles Incident Cases.
- Gender-specific Shingles Incident Cases.
- Age-specific Shingles Incident Cases.
- Shingles Diagnosed and Treatable Cases.
Visit for information- Shingles Market Insights
Shingles rates have been increasing in the United States over a long period of time and the reasons for this are unclear. This trend continues among younger and middle aged adults, however since 2008 the rates among older adults have been plateauing.
Shingrix is a new shingles vaccine developed by GlaxoSmithKline and was approved by the US FDA in 2017. It contains inactivated varicella-zoster viral particles, which aids the body’s production of more antibodies that are necessary to fight the virus with a stronger immune system response.
- Famvir (famciclovir)
- Valtrex (Valacyclovir)
- Amenalief (amenamevir)
- Shingrix
- And many others
- Novartis,
- GlaxoSmithKline,
- Maruho,
- and many others.
Shingles Market Report Key Strengths
- 10 Years Forecast
- 7MM Coverage
- Tendinopathy Epidemiology Segmentation
- Key Cross Competition
- Highly Analyzed Market
- Drugs Uptake
Key Questions Answered in the Shingles Market Report–
- What was the Shingles market share (%) distribution in 2017 and how it would look like in 2030?
- What would be the Shingles total market size as well as market size by therapies across the 7MM during the forecast period (2017-2030)?
- What are the key findings pertaining to the market across 7MM and which country will have the largest Shingles market size during the forecast period (2017-2030)?
- At what CAGR, is the Shingles market expected to grow in the 7MM during the forecast period (2017-2030)?
- What would be the Shingles market outlook across the 7MM during the forecast period (2017-2030)?
- What would be the Shingles market growth till 2030, and what will be the resultant market Size in the year 2030?
- How would the market drivers, barriers, and future opportunities affect the market dynamics and subsequent analysis of the associated trends?
You may speak to our experts- Shingles Market Report
Read Detailed Table of Content
- Key Insights
- Executive Summary of Shingles
- Competitive Intelligence Analysis for Shingles
- Shingles: Market Overview at a Glance
- Shingles: Disease Background and Overview
- Patient Journey
- Shingles Epidemiology and Patient Population
- Treatment Algorithm, Current Treatment, and Medical Practices
- Unmet Needs
- Key Endpoints of Shingles Treatment
- Marketed Products
- Emerging Therapies
- Shingles: Seven Major Market Analysis
- Attribute analysis
- 7MM: Market Outlook
- Access and Reimbursement Overview of Shingles
- KOL Views
- Market Drivers
- Market Barriers
- Appendix
- DelveInsight Capabilities
- Disclaimer
- About DelveInsight
Know More about the report- Shingles Market Outlook
Related Reports
DelveInsight’s Herpes Zoster Market Insights, Epidemiology and Market Forecast – 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology.
DelveInsight’s s Human Papillomavirus (HPV) – Market Insights, Epidemiology and Market Forecast – 2030 report provides a detailed overview of the disease and in-depth understanding.
DelveInsight’s Pneumonia, Pneumococcal – Market Insights, Epidemiology and Market Forecast – 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology.
DelveInsight’s s Meningitis – Market Insights, Epidemiology, and Market Forecast – 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology.
DelveInsight’s s Hepatitis B Virus (HBV) Infection – Market Insights, Epidemiology, and Market Forecast – 2030 report provides a detailed overview of the disease and a depth understanding of historical and forecasted epidemiology.
Visit our blog section
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences providing comprehensive end-to-end solutions to improve performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve
For more insights into the Pharma industry, Visit Pharma, Healthcare, and Biotech Blog
Contact Information:
Shruti Thakur info@delveinsight.com +91-9650213330
Tags:
Menafn, IPS, Reportedtimes, PR-Wirein, iCN Internal Distribution, Extended Distribution, Research Newswire, English
Contact Information:
Shruti Thakur
info@delveinsight.com
+91-9650213330